The Impella 2.5 L for percutaneous mechanical circulatory support in severe humoral allograft rejection.
Heart transplant recipients who experience humoral rejection are at risk for hemodynamic instability. We report a case of a 64-year-old male with cardiogenic shock due to allograft rejection requiring mechanical support while undergoing intense immunosuppression. He underwent implantation of a micro-axial endovascular pump (Impella). To our knowledge, this is the first reported case of successful Impella device deployment as a bridge-to-recovery strategy.
Beyer
Anna T
AT
Cardiology Department, California Pacific Medical Center, 2333 Buchanan Street, San Francisco, CA 94115, USA. abeyer@gmail.com.
Hui
Peter Y
PY
Hauesslein
Ernest
E
D001706:Biopsy; D006084:Graft Rejection / Q000150:complications / Q000276:immunology* / Q000628:therapy; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006353:Heart-Assist Devices; D006801:Humans; D056724:Immunity, Humoral / Q000276:immunology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D010956:Plasmapheresis; D012770:Shock, Cardiogenic / Q000209:etiology / Q000628:therapy*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous